{"id":8322,"date":"2026-07-15T09:38:15","date_gmt":"2026-07-15T01:38:15","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-07-15\/"},"modified":"2026-07-15T09:38:15","modified_gmt":"2026-07-15T01:38:15","slug":"9-94","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-94\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-15\uff5cBiogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-07-15\">2026 \u5e74 07 \u6708 15 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/biogen-defends-anti-tau-drug-after-stock-slides-alzheimers-readout\" rel=\"noopener nofollow\" target=\"_blank\">Biogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u6578\u64da\u516c\u5e03\u5f8c\u80a1\u50f9\u4e0b\u6ed1<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-07-15\" itemprop=\"datePublished\">2026-07-15<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>BIIB<\/b> Biogen <span class=\"chg chg-down\">\u25bc8.17% $191.95<\/span><\/span><span class=\"stk stk-other\"><b>4523<\/b> Eisai <span class=\"chg chg-down\">\u25bc2.42% $4270.0<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-down\">\u25bc2.48% $1152.54<\/span><\/span><span class=\"stk stk-other\"><b>ROG<\/b> Roche <span class=\"chg chg-up\">\u25b22.05% $137.59<\/span><\/span><span class=\"stk stk-us\"><b>ABBV<\/b> AbbVie <span class=\"chg chg-down\">\u25bc1.30% $244.78<\/span><\/span><span class=\"stk stk-tw\"><b>4147<\/b> \u4e2d\u88d5\u65b0\u85e5 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Biogen \u516c\u5e03\u5176\u6297 tau \u86cb\u767d\u85e5\u7269\uff08anti-tau \u7642\u6cd5\uff09\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u8a66\u9a57\u6578\u64da\u5f8c\uff0c\u5e02\u5834\u53cd\u61c9\u51b7\u6de1\uff0c\u80a1\u50f9\u51fa\u73fe\u660e\u986f\u4e0b\u6ed1\u3002\u9762\u5c0d\u6295\u8cc7\u4eba\u7591\u616e\uff0cBiogen \u7ba1\u7406\u5c64\u4e3b\u52d5\u51fa\u9762\u70ba\u8a72\u85e5\u7269\u8faf\u8b77\uff0c\u5f37\u8abf\u6578\u64da\u4ecd\u5177\u81e8\u5e8a\u610f\u7fa9\u3002\u6b64\u4e8b\u4ef6\u518d\u5ea6\u51f8\u986f\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u958b\u767c\u9ad8\u5ea6\u56f0\u96e3\uff0c\u7e7c amyloid \u8def\u7dda\u4e4b\u5f8c\uff0ctau \u86cb\u767d\u8def\u7dda\u80fd\u5426\u6210\u70ba\u4e0b\u4e00\u500b\u7a81\u7834\u53e3\u4ecd\u5b58\u9ad8\u5ea6\u4e0d\u78ba\u5b9a\u6027\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>Biogen \u80a1\u7968\u56e0\u6578\u64da\u516c\u5e03\u5f8c\u55ae\u65e5\u51fa\u73fe\u986f\u8457\u8dcc\u5e45\uff08\u5e02\u5834\u9810\u671f\u843d\u7a7a\uff09\uff1b\u963f\u8332\u6d77\u9ed8\u75c7\u5168\u7403\u60a3\u8005\u4eba\u6578\u4f30\u8a08\u8d85\u904e 5,500 \u842c\u4eba\uff0c\u5e02\u5834\u898f\u6a21\u9f90\u5927\uff1bBiogen \u65d7\u4e0b lecanemab\uff08Leqembi\uff09\u65bc 2023 \u5e74\u7372 FDA \u5b8c\u6574\u6838\u51c6\uff0c\u5b9a\u50f9\u6bcf\u5e74\u7d04 26,500 \u7f8e\u5143\uff0c\u4f46\u5546\u696d\u5316\u9032\u5c55\u9060\u4f4e\u65bc\u9810\u671f\uff1btau \u86cb\u767d\u7642\u6cd5\u70ba\u7e7c amyloid \u6e05\u9664\u7b56\u7565\u5f8c\u696d\u754c\u5bc4\u4e88\u539a\u671b\u7684\u7b2c\u4e8c\u689d\u4e3b\u7dda\uff0c\u5168\u7403\u81f3\u5c11\u6709 15 \u500b\u4ee5\u4e0a tau \u9776\u5411\u5019\u9078\u85e5\u7269\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Biogen \u6297 tau \u85e5\u7269\u6578\u64da\u4ee4\u5e02\u5834\u5931\u671b\uff0c\u986f\u793a\u963f\u8332\u6d77\u9ed8\u75c7\u7684\u300etau \u8def\u7dda\u300f\u77ed\u671f\u5167\u96e3\u4ee5\u8907\u88fd amyloid \u7642\u6cd5\u7684\u7a81\u7834\u683c\u5c40\uff0c\u5c07\u8feb\u4f7f\u6574\u500b\u9818\u57df\u91cd\u65b0\u8a55\u4f30 tau \u9776\u5411\u7b56\u7565\u7684\u6295\u8cc7\u512a\u5148\u9806\u5e8f\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cBiogen \u672c\u8eab\u5728 amyloid \u7642\u6cd5\uff08Leqembi\uff09\u5546\u696d\u5316\u5df2\u9762\u81e8\u6ef2\u900f\u7387\u4e0d\u4f73\u7684\u56f0\u5883\uff0c\u82e5 tau \u7ba1\u7dda\u53c8\u544a\u6298\u632b\uff0c\u516c\u53f8\u6838\u5fc3\u795e\u7d93\u79d1\u5b78\u7ba1\u7dda\u5c07\u5927\u5e45\u627f\u58d3\u3002\u6b64\u6b21\u632b\u6298\u4e5f\u9593\u63a5\u5229\u597d Eli Lilly \u7684 donanemab \u53ca Roche \u7684 gantenerumab \u5f8c\u7e7c\u8005\uff0c\u56e0\u7af6\u722d\u7126\u9ede\u5c07\u66f4\u96c6\u4e2d\u65bc\u5df2\u9a57\u8b49\u7684 amyloid \u6e05\u9664\u8def\u7dda\u3002\u5c0d\u53f0\u7063\u795e\u7d93\u9000\u5316\u76f8\u95dc\u751f\u91ab\u5ee0\u5546\u800c\u8a00\uff0c\u6b64\u4e8b\u4ef6\u63d0\u793a tau \u9776\u5411\u65e9\u671f\u6388\u6b0a\u8ac7\u5224\u7c4c\u78bc\u77ed\u671f\u8d70\u5f31\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u5373\u4fbf Biogen \u7ba1\u7406\u5c64\u51fa\u9762\u8b77\u76e4\u8aaa\u6cd5\uff0c\u4f46\u963f\u8332\u6d77\u9ed8\u75c7\u65b0\u85e5\u5c62\u6b21\u5728\u5f8c\u671f\u81e8\u5e8a\u5931\u6557\u7684\u6b77\u53f2\uff08\u8d85\u904e 99% \u7684\u8a66\u9a57\u5931\u6557\u7387\uff09\u986f\u793a\uff0c\u55ae\u6191\u516c\u53f8\u8faf\u8b77\u8072\u660e\u96e3\u4ee5\u91cd\u5efa\u6295\u8cc7\u4fe1\u5fc3\uff1b\u66f4\u6839\u672c\u7684\u554f\u984c\u662f\uff0ctau \u86cb\u767d\u75c5\u7406\u5728\u963f\u8332\u6d77\u9ed8\u75c7\u4e2d\u662f\u56e0\u9084\u662f\u679c\u81f3\u4eca\u4ecd\u6709\u722d\u8b70\uff0c\u82e5\u9776\u9ede\u9078\u64c7\u672c\u8eab\u5c31\u5b58\u5728\u6839\u672c\u6027\u7591\u554f\uff0c\u518d\u591a\u7684\u81e8\u5e8a\u512a\u5316\u4e5f\u53ef\u80fd\u5f92\u52de\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Biogen \u53ec\u958b\u6295\u8cc7\u4eba\u6cd5\u8aaa\u6703\u6216\u79d1\u5b78\u8aaa\u660e\u6703\uff0c\u9032\u4e00\u6b65\u516c\u958b\u5b8c\u6574\u81e8\u5e8a\u6578\u64da\u5b50\u96c6\u5206\u6790<\/li><li>FDA \u6216 EMA \u5c0d\u6b64\u6b21 tau \u85e5\u7269\u6578\u64da\u7684\u76e3\u7ba1\u56de\u994b\u610f\u898b\u662f\u5426\u51fa\u73fe<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>Biogen \u662f\u5426\u8abf\u6574 tau \u85e5\u7269\u5f8c\u7e8c\u8a66\u9a57\u8a2d\u8a08\uff08\u5982\u91cd\u65b0\u5b9a\u7fa9\u60a3\u8005\u65cf\u7fa4\u6216\u5291\u91cf\uff09<\/li><li>\u7af6\u722d\u5c0d\u624b AbbVie\u3001Roche \u7b49 tau \u7ba1\u7dda\u5728\u4e2d\u671f\u6578\u64da\u4e0a\u7684\u8868\u73fe\u662f\u5426\u540c\u6a23\u627f\u58d3<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>tau \u9776\u5411\u7642\u6cd5\u662f\u5426\u80fd\u627e\u5230\u53ef\u9760\u7684\u751f\u7269\u6a19\u8a18\uff08biomarker\uff09\u4ee5\u5be6\u73fe\u7cbe\u6e96\u75c5\u60a3\u7be9\u9078<\/li><li>Biogen \u795e\u7d93\u79d1\u5b78\u7ba1\u7dda\u6574\u9ad4\u8f49\u578b\u65b9\u5411\uff0c\u662f\u5426\u8f49\u5411 AI \u9a45\u52d5\u7684\u65b0\u9776\u9ede\u6216\u57fa\u56e0\u7642\u6cd5<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>Biogen \u7684\u6297 tau \u85e5\u7269\u548c\u4e4b\u524d\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f<\/summary><p>\u904e\u53bb Biogen \u7684 Leqembi \u662f\u6e05\u9664\u5927\u8166\u4e2d\u7684 amyloid \u6591\u584a\uff0c\u800c\u6297 tau \u85e5\u7269\u7684\u76ee\u6a19\u662f\u53e6\u4e00\u7a2e\u75c5\u7406\u86cb\u767d\u2014\u2014tau \u7e8f\u7d50\uff1b\u79d1\u5b78\u754c\u8a8d\u70ba\u5169\u7a2e\u75c5\u7406\u90fd\u662f\u963f\u8332\u6d77\u9ed8\u75c7\u7684\u6838\u5fc3\u7279\u5fb5\uff0c\u4f46 tau \u8def\u7dda\u5c1a\u672a\u6709\u4efb\u4f55\u85e5\u7269\u6210\u529f\u901a\u904e\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a57\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>Biogen \u80a1\u50f9\u4e0b\u8dcc\u4ee3\u8868\u9019\u500b\u85e5\u7269\u5b8c\u5168\u5931\u6557\u4e86\u55ce\uff1f<\/summary><p>\u4e0d\u4e00\u5b9a\u662f\u5b8c\u5168\u5931\u6557\uff0c\u4f46\u6578\u64da\u672a\u9054\u5e02\u5834\u9810\u671f\u662f\u4e3b\u56e0\uff1bBiogen \u7ba1\u7406\u5c64\u6b63\u4e3b\u5f35\u90e8\u5206\u6b21\u65cf\u7fa4\uff08subgroup\uff09\u4ecd\u6709\u7642\u6548\u4fe1\u865f\uff0c\u5f8c\u7e8c\u662f\u5426\u7e7c\u7e8c\u958b\u767c\u53d6\u6c7a\u65bc\u66f4\u5b8c\u6574\u7684\u6578\u64da\u5206\u6790\u8207\u76e3\u7ba1\u6a5f\u69cb\u6e9d\u901a\u7d50\u679c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u6b21\u5931\u6557\u5c0d\u5176\u4ed6\u516c\u53f8\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u7814\u767c\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f<\/summary><p>\u77ed\u671f\u5167\u5c07\u4f7f tau \u9776\u5411\u85e5\u7269\u7684\u6388\u6b0a\u8207\u878d\u8cc7\u96e3\u5ea6\u63d0\u9ad8\uff0c\u8cc7\u91d1\u53ef\u80fd\u66f4\u96c6\u4e2d\u6d41\u5411\u5df2\u6709\u81e8\u5e8a\u9a57\u8b49\u7684 amyloid \u6e05\u9664\u7642\u6cd5\uff08\u5982 Lilly \u7684 donanemab\uff09\uff1b\u4f46\u9577\u671f\u800c\u8a00\u4e26\u4e0d\u4ee3\u8868 tau \u7b56\u7565\u5df2\u6b7b\uff0c\u7cbe\u6e96\u60a3\u8005\u5206\u5c64\u4ecd\u662f\u53ef\u80fd\u7684\u7834\u5c40\u95dc\u9375\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/biogen-defends-anti-tau-drug-after-stock-slides-alzheimers-readout\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/avere-launches-trifecta-chinese-license-reverse-merger-and-320m-advance-oral-inflammatory\" rel=\"noopener nofollow\" target=\"_blank\">Avere \u900f\u904e NextCure \u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff0c\u4ee5 23 \u5104\u7f8e\u5143\u4ea4\u6613\u53d6\u5f97\u7ff0\u68ee\u88fd\u85e5 IL-23 \u85e5\u7269\u6388\u6b0a<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-07-15\" itemprop=\"datePublished\">2026-07-15<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\">Avere Therapeutics <span class=\"chg chg-flat\">\u672a\u4e0a\u5e02<\/span><\/span><span class=\"stk stk-us\"><b>NXTC<\/b> NextCure <span class=\"chg chg-up\">\u25b2201.83% $6.58<\/span><\/span><span class=\"stk stk-other\"><b>3692<\/b> \u7ff0\u68ee\u88fd\u85e5\uff08Hansoh Pharma\uff09 <span class=\"chg chg-up\">\u25b20.12% $32.56<\/span><\/span><span class=\"stk stk-us\"><b>ABBV<\/b> AbbVie <span class=\"chg chg-down\">\u25bc1.30% $244.78<\/span><\/span><span class=\"stk stk-us\"><b>JNJ<\/b> Johnson &amp; Johnson <span class=\"chg chg-down\">\u25bc1.52% $253.85<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-down\">\u25bc2.48% $1152.54<\/span><\/span><span class=\"stk stk-tw\"><b>4131<\/b> \u53cb\u83ef\u751f\u6280\u91ab\u85e5 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u7f8e\u570b\u751f\u6280\u65b0\u5275 Avere Therapeutics \u900f\u904e\u8207 NextCure \u9032\u884c\u53cd\u5411\u4f75\u8cfc\uff08reverse merger\uff09\u7684\u65b9\u5f0f\u5b8c\u6210\u4e0a\u5e02\uff0c\u540c\u6b65\u5ba3\u5e03\u4ee5\u6700\u9ad8 23 \u5104\u7f8e\u5143\u7684\u4ea4\u6613\u91d1\u984d\uff08\u5305\u542b\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff09\u53d6\u5f97\u4e2d\u570b\u7ff0\u68ee\u88fd\u85e5\u4e00\u6b3e\u53e3\u670d IL-23 \u6291\u5236\u5291\u7684\u5168\u7403\u6388\u6b0a\uff08\u4e2d\u570b\u4ee5\u5916\u5e02\u5834\uff09\u3002\u6b64\u4e09\u9023\u767c\u7b56\u7565\uff08\u501f\u6bbc\u4e0a\u5e02\uff0b\u4e2d\u570b\u6388\u6b0a\u5f15\u9032\uff0b\u878d\u8cc7\uff09\u986f\u793a Avere \u8a66\u5716\u5728\u767c\u708e\u514d\u75ab\u75be\u75c5\u9818\u57df\u5feb\u901f\u5efa\u7acb\u5dee\u7570\u5316\u7ba1\u7dda\uff0c\u4e26\u5229\u7528\u4e2d\u570b\u5275\u65b0\u85e5\u7684\u6027\u50f9\u6bd4\u512a\u52e2\u5207\u5165\u7af6\u722d\u6fc0\u70c8\u7684 IL-23 \u5e02\u5834\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u4ea4\u6613\u7e3d\u91d1\u984d\u6700\u9ad8\u9054 23 \u5104\u7f8e\u5143\uff08\u542b\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff09\uff1b\u9810\u4ed8\u6b3e\uff08advance\uff09\u5831\u5c0e\u63d0\u53ca\u7d04 3.2 \u5104\u7f8e\u5143\u73fe\u91d1\u5148\u671f\u652f\u4ed8\uff1bIL-23 \u6291\u5236\u5291\u5168\u7403\u5e02\u5834\u76ee\u524d\u7531 J&amp;J \u7684 Tremfya\uff08guselkumab\uff09\u3001AbbVie \u7684 Skyrizi\uff08risankizumab\uff09\u4e3b\u5c0e\uff0c2023 \u5e74 Skyrizi \u5168\u7403\u92b7\u552e\u984d\u7a81\u7834 90 \u5104\u7f8e\u5143\uff1b\u53e3\u670d IL-23 \u70ba\u4e0b\u4e00\u4ee3\u5dee\u7570\u5316\u7af6\u722d\u7126\u9ede\uff0c\u76ee\u524d\u5c1a\u7121\u53e3\u670d IL-23 \u6291\u5236\u5291\u7372 FDA \u6838\u51c6\uff1bNextCure \u501f\u6bbc\u524d\u5e02\u503c\u50c5\u7d04\u6578\u5343\u842c\u7f8e\u5143\uff0c\u5c6c\u5178\u578b\u6bbc\u516c\u53f8\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Avere \u4ee5 23 \u5104\u7f8e\u5143\u5f15\u9032\u7ff0\u68ee\u53e3\u670d IL-23 \u6291\u5236\u5291\uff0c\u6a19\u8a8c\u8457\u300c\u4e2d\u570b\u5275\u65b0\u85e5 license-out \u81f3\u897f\u65b9\u5e02\u5834\u300d\u7684\u4ea4\u6613\u6a21\u5f0f\u5df2\u9032\u5165\u5927\u984d\u5316\u3001\u4e3b\u6d41\u5316\u968e\u6bb5\uff0c\u5c0d\u6574\u500b\u767c\u708e\u514d\u75ab\u75be\u75c5\u8cfd\u9053\u5177\u6709\u6307\u6a19\u610f\u7fa9\u3002\u53e3\u670d\u5291\u578b\u662f IL-23 \u5e02\u5834\u7684\u4e0b\u4e00\u500b\u7af6\u722d\u5236\u9ad8\u9ede\u2014\u2014\u82e5\u80fd\u5728\u76ae\u4e0b\u6ce8\u5c04\u7684 Skyrizi\u3001Tremfya \u4e4b\u524d\u63a8\u51fa\u6709\u6548\u53e3\u670d\u7248\u672c\uff0c\u5e02\u5834\u985b\u8986\u7a7a\u9593\u5de8\u5927\u3002\u6b64\u6a21\u5f0f\u540c\u6642\u5c0d\u53f0\u7063 CDMO \u8207\u514d\u75ab\u75be\u75c5\u7814\u767c\u5ee0\u5546\u5f62\u6210\u793a\u7bc4\u6548\u61c9\uff1a\u4e2d\u570b\u5275\u65b0\u85e5\u7684\u6210\u672c\u6548\u7387\u512a\u52e2\u6b63\u88ab\u897f\u65b9\u8cc7\u672c\u5e02\u5834\u91cd\u65b0\u5b9a\u50f9\uff0c\u5f15\u767c\u66f4\u591a\u8de8\u5883\u6388\u6b0a\u7af6\u722d\u3002\u501f\u6bbc\u4e0a\u5e02\uff08SPAC\/reverse merger\uff09\u7d50\u5408\u5927\u578b\u6388\u6b0a\u7684\u300c\u4e00\u9b5a\u4e09\u5403\u300d\u7b56\u7565\uff0c\u4e5f\u9810\u793a\u672a\u4f86\u751f\u6280\u878d\u8cc7\u67b6\u69cb\u7684\u5275\u65b0\u65b9\u5411\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u53e3\u670d IL-23 \u6291\u5236\u5291\u6280\u8853\u53ef\u884c\u6027\u4ecd\u5f85\u9a57\u8b49\uff0c\u5927\u5206\u5b50\u6297\u9ad4\u53e3\u670d\u7d66\u85e5\u7684\u751f\u7269\u5229\u7528\u5ea6\u6311\u6230\u81f3\u4eca\u672a\u5b8c\u5168\u514b\u670d\uff0c23 \u5104\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u4ed8\u6b3e\u9ad8\u5ea6\u4f9d\u8cf4\u5f8c\u671f\u81e8\u5e8a\u6210\u529f\uff0c\u800c\u7ff0\u68ee\u539f\u59cb\u6578\u64da\u591a\u4f86\u81ea\u4e2d\u570b\u4eba\u7fa4\uff0c\u80fd\u5426\u76f4\u63a5\u5916\u63a8\u81f3\u897f\u65b9\u591a\u7a2e\u65cf\u65cf\u7fa4\u5b58\u5728\u76e3\u7ba1\u8207\u79d1\u5b78\u4e0d\u78ba\u5b9a\u6027\uff1b\u52a0\u4e0a IL-23 \u5e02\u5834\u5df2\u88ab AbbVie Skyrizi \u9ad8\u5ea6\u58df\u65b7\uff0c\u65b0\u9032\u8005\u9700\u8981\u6975\u5f37\u7684\u7642\u6548\u6216\u5b89\u5168\u6027\u5dee\u7570\u624d\u80fd\u64bc\u52d5\u5e02\u5834\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Avere \u501f\u6bbc\u5b8c\u6210\u5f8c\u5728 NASDAQ \u7684\u9996\u65e5\u639b\u724c\u8868\u73fe\u8207\u6a5f\u69cb\u8a8d\u8cfc\u60c5\u6cc1<\/li><li>\u7ff0\u68ee IL-23 \u53e3\u670d\u5019\u9078\u85e5\u7269\u73fe\u6709\u81e8\u5e8a\u6578\u64da\u5305\uff08\u4e2d\u570b Phase I\/II \u7d50\u679c\uff09\u6b63\u5f0f\u5c0d\u5916\u63ed\u9732<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>Avere \u555f\u52d5\u7f8e\u570b\u6216\u6b50\u6d32 Phase II \u81e8\u5e8a\u8a66\u9a57\u7684\u6642\u9593\u8868\u8207\u60a3\u8005\u5165\u7d44\u901f\u5ea6<\/li><li>AbbVie\u3001J&amp;J \u7b49\u5927\u5ee0\u662f\u5426\u52a0\u901f\u81ea\u8eab\u53e3\u670d IL-23 \u7ba1\u7dda\u7814\u767c\u4ee5\u61c9\u5c0d\u7af6\u722d<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u53e3\u670d IL-23 \u6291\u5236\u5291\u80fd\u5426\u7a81\u7834\u751f\u7269\u5229\u7528\u5ea6\u6280\u8853\u74f6\u9838\u4e26\u53d6\u5f97 FDA \u6838\u51c6<\/li><li>\u4e2d\u570b\u5275\u65b0\u85e5 license-out \u6a21\u5f0f\u662f\u5426\u9762\u81e8\u7f8e\u570b\u5c0d\u4e2d\u570b\u751f\u6280\u8cc7\u7522\u7684\u76e3\u7ba1\u5be9\u67e5\u98a8\u96aa\uff08\u5982 BIOSECURE Act \u5ef6\u4f38\u5f71\u97ff\uff09<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u4ec0\u9ebc\u662f\u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff1fAvere \u70ba\u4ec0\u9ebc\u4e0d\u9078\u64c7\u50b3\u7d71 IPO\uff1f<\/summary><p>\u53cd\u5411\u4f75\u8cfc\u662f\u6307\u79c1\u4eba\u516c\u53f8\u6536\u8cfc\u4e00\u5bb6\u5df2\u4e0a\u5e02\u4f46\u696d\u52d9\u505c\u6eef\u7684\u6bbc\u516c\u53f8\uff08\u6b64\u8655\u70ba NextCure\uff09\uff0c\u85c9\u6b64\u7e5e\u904e\u50b3\u7d71 IPO \u7e41\u8907\u5be9\u67e5\u6d41\u7a0b\u5feb\u901f\u639b\u724c\uff1b\u5728\u7576\u524d\u751f\u6280 IPO \u5e02\u5834\u4f4e\u8ff7\u3001\u5be9\u67e5\u56b4\u683c\u7684\u74b0\u5883\u4e0b\uff0c\u6b64\u65b9\u5f0f\u53ef\u7bc0\u7701\u6642\u9593\u8207\u627f\u92b7\u6210\u672c\uff0c\u4f46\u4ee3\u50f9\u662f\u9700\u627f\u63a5\u6bbc\u516c\u53f8\u7684\u6b77\u53f2\u80a1\u6771\u7d50\u69cb\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>IL-23 \u6291\u5236\u5291\u548c\u76ee\u524d\u5e02\u5834\u4e0a\u7684\u751f\u7269\u88fd\u5291\u6709\u4ec0\u9ebc\u7af6\u722d\u512a\u52e2\uff1f<\/summary><p>\u73fe\u6709 IL-23 \u6291\u5236\u5291\uff08\u5982 Skyrizi\u3001Tremfya\uff09\u5747\u70ba\u6ce8\u5c04\u5291\u578b\uff0c\u82e5 Avere \u5f15\u9032\u7684\u7ff0\u68ee\u85e5\u7269\u80fd\u5be6\u73fe\u53e3\u670d\u7d66\u85e5\uff0c\u5c07\u5927\u5e45\u63d0\u5347\u60a3\u8005\u7528\u85e5\u4fbf\u5229\u6027\uff0c\u6709\u6a5f\u6703\u5728\u4e7e\u766c\u3001\u767c\u708e\u6027\u8178\u75c5\u7b49\u6162\u6027\u9069\u61c9\u75c7\u4e2d\u6436\u5360\u5e02\u4f54\uff1b\u53e3\u670d\u7d66\u85e5\u662f\u6574\u500b\u514d\u75ab\u9818\u57df\u516c\u8a8d\u7684\u4e0b\u4e00\u500b\u5dee\u7570\u5316\u6230\u5834\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u7ff0\u68ee\u88fd\u85e5\u7684\u85e5\u7269\u5728\u4e2d\u570b\u5df2\u7d93\u4e0a\u5e02\u4e86\u55ce\uff1f\u9019\u6b21\u4ea4\u6613\u53ea\u6388\u6b0a\u54ea\u4e9b\u5730\u5340\uff1f<\/summary><p>\u6839\u64da\u4ea4\u6613\u67b6\u69cb\uff0cAvere \u53d6\u5f97\u7684\u662f\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5e02\u5834\u6b0a\u5229\uff0c\u7ff0\u68ee\u4fdd\u7559\u4e2d\u570b\u5e02\u5834\uff1b\u8a72\u53e3\u670d IL-23 \u5019\u9078\u85e5\u7269\u76ee\u524d\u7814\u5224\u4ecd\u8655\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0c\u5c1a\u672a\u5728\u4efb\u4f55\u4e3b\u8981\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff0cAvere \u9700\u81ea\u884c\u63a8\u9032\u897f\u65b9\u5e02\u5834\u7684\u5f8c\u671f\u81e8\u5e8a\u8207\u85e5\u8b49\u7533\u8acb\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/avere-launches-trifecta-chinese-license-reverse-merger-and-320m-advance-oral-inflammatory\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/summit-sells-failed-antibiotic-openai-backed-startup-105m-deal\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/summit-sells-failed-antibiotic-openai-backed-startup-105m-deal&#8221; hreflang=&#8221;en&#8221;&gt;Summit sells failed antibiotic to OpenAI-backed startup in $105M deal&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/research\/cepi-backed-ebola-vaccine-set-enter-phase-1-trials\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/research\/cepi-backed-ebola-vaccine-set-enter-phase-1-trials&#8221; hreflang=&#8221;en&#8221;&gt;CEPI-backed Ebola vaccine set to enter phase 1 trials&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/pharma\/fda-approval-its-breast-cancer-blockbuster-hopeful-celcuity-could-belong-hands-big-pharma\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/pharma\/fda-approval-its-breast-cancer-blockbuster-hopeful-celcuity-could-belong-hands-big-pharma&#8221; hreflang=&#8221;en&#8221;&gt;With FDA approval for its breast cancer blockbuster hopeful, Celcuity could &#8216;belong in the hands&#8217; of a Big Pharma&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/money.udn.com\/money\/story\/10871\/9622115\" rel=\"noopener nofollow\" target=\"_blank\">08:40 \u751f\u6280\u9ec3\u91d1\u6536\u6210\u5e741\uff0f30\u5e74\u9577\u5f81 \u53f0\u7063\u751f\u6280\u696d\u7684\u9ec3\u91d1\u5e74\u4ee3\u4f86\u4e86\uff1f<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 \u7d93\u6fdf\u65e5\u5831\u79d1\u6280\u7248<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/cro\/over-half-clinical-trial-sites-seeing-recruitment-hindered-inefficiencies-survey\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/cro\/over-half-clinical-trial-sites-seeing-recruitment-hindered-inefficiencies-survey&#8221; hreflang=&#8221;en&#8221;&gt;Over half of clinical trial sites see recruitment hindered by inefficiencies: survey&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/fda-plans-release-more-drug-rejection-letters-controversial-policy-resumes\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/fda-plans-release-more-drug-rejection-letters-controversial-policy-resumes&#8221; hreflang=&#8221;en&#8221;&gt;FDA plans to release more drug rejection letters as controversial policy resumes&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:100.0%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">8<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 07 \u6708 15 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-15\uff5cBiogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7","rank_math_description":"2026 \u5e74 07 \u6708 15 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aBiogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u6578\u64da\u516c\u5e03\u5f8c\u80a1\u50f9\u3001Avere \u900f\u904e NextCure \u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff0c\u4ee5 23 \u5104\u7f8e\u5143\u4ea4\u6613\u3002\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-07-15\uff5cBiogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\",\n    \"description\": \"2026 \u5e74 07 \u6708 15 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aBiogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u6578\u64da\u516c\u5e03\u5f8c\u80a1\u50f9\u3001Avere \u900f\u904e NextCure \u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff0c\u4ee5 23 \u5104\u7f8e\u5143\u4ea4\u6613\u3002\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-15\",\n    \"datePublished\": \"2026-07-15\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Biogen \u70ba\u6297 tau \u86cb\u767d\u85e5\u7269\u8faf\u8b77\uff0c\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u6578\u64da\u516c\u5e03\u5f8c\u80a1\u50f9\u4e0b\u6ed1\",\n        \"datePublished\": \"2026-07-15\",\n        \"dateModified\": \"2026-07-15\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-07-15#article-1\"\n        },\n        \"description\": \"Biogen \u516c\u5e03\u5176\u6297 tau \u86cb\u767d\u85e5\u7269\uff08anti-tau \u7642\u6cd5\uff09\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u81e8\u5e8a\u8a66\u9a57\u6578\u64da\u5f8c\uff0c\u5e02\u5834\u53cd\u61c9\u51b7\u6de1\uff0c\u80a1\u50f9\u51fa\u73fe\u660e\u986f\u4e0b\u6ed1\u3002\u9762\u5c0d\u6295\u8cc7\u4eba\u7591\u616e\uff0cBiogen \u7ba1\u7406\u5c64\u4e3b\u52d5\u51fa\u9762\u70ba\u8a72\u85e5\u7269\u8faf\u8b77\uff0c\u5f37\u8abf\u6578\u64da\u4ecd\u5177\u81e8\u5e8a\u610f\u7fa9\u3002\u6b64\u4e8b\u4ef6\u518d\u5ea6\u51f8\u986f\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u958b\u767c\u9ad8\u5ea6\u56f0\u96e3\uff0c\u7e7c amyloid \u8def\u7dda\u4e4b\u5f8c\uff0ctau \u86cb\u767d\u8def\u7dda\u80fd\u5426\u6210\u70ba\u4e0b\u4e00\u500b\u7a81\u7834\u53e3\u4ecd\u5b58\u9ad8\u5ea6\u4e0d\u78ba\u5b9a\u6027\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-15#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/biogen-defends-anti-tau-drug-after-stock-slides-alzheimers-readout\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Biogen\",\n            \"tickerSymbol\": \"BIIB\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eisai\",\n            \"tickerSymbol\": \"4523\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"ROG\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AbbVie\",\n            \"tickerSymbol\": \"ABBV\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e2d\u88d5\u65b0\u85e5\",\n            \"tickerSymbol\": \"4147\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Avere \u900f\u904e NextCure \u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff0c\u4ee5 23 \u5104\u7f8e\u5143\u4ea4\u6613\u53d6\u5f97\u7ff0\u68ee\u88fd\u85e5 IL-23 \u85e5\u7269\u6388\u6b0a\",\n        \"datePublished\": \"2026-07-15\",\n        \"dateModified\": \"2026-07-15\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-07-15#article-2\"\n        },\n        \"description\": \"\u7f8e\u570b\u751f\u6280\u65b0\u5275 Avere Therapeutics \u900f\u904e\u8207 NextCure \u9032\u884c\u53cd\u5411\u4f75\u8cfc\uff08reverse merger\uff09\u7684\u65b9\u5f0f\u5b8c\u6210\u4e0a\u5e02\uff0c\u540c\u6b65\u5ba3\u5e03\u4ee5\u6700\u9ad8 23 \u5104\u7f8e\u5143\u7684\u4ea4\u6613\u91d1\u984d\uff08\u5305\u542b\u91cc\u7a0b\u7891\u4ed8\u6b3e\uff09\u53d6\u5f97\u4e2d\u570b\u7ff0\u68ee\u88fd\u85e5\u4e00\u6b3e\u53e3\u670d IL-23 \u6291\u5236\u5291\u7684\u5168\u7403\u6388\u6b0a\uff08\u4e2d\u570b\u4ee5\u5916\u5e02\u5834\uff09\u3002\u6b64\u4e09\u9023\u767c\u7b56\u7565\uff08\u501f\u6bbc\u4e0a\u5e02\uff0b\u4e2d\u570b\u6388\u6b0a\u5f15\u9032\uff0b\u878d\u8cc7\uff09\u986f\u793a Avere \u8a66\u5716\u5728\u767c\u708e\u514d\u75ab\u75be\u75c5\u9818\u57df\u5feb\u901f\u5efa\u7acb\u5dee\u7570\u5316\u7ba1\u7dda\uff0c\u4e26\u5229\u7528\u4e2d\u570b\u5275\u65b0\u85e5\u7684\u6027\u50f9\u6bd4\u512a\u52e2\u5207\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-07-15#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/avere-launches-trifecta-chinese-license-reverse-merger-and-320m-advance-oral-inflammatory\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Avere Therapeutics\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"NextCure\",\n            \"tickerSymbol\": \"NXTC\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u7ff0\u68ee\u88fd\u85e5\uff08Hansoh Pharma\uff09\",\n            \"tickerSymbol\": \"3692\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AbbVie\",\n            \"tickerSymbol\": \"ABBV\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Johnson & Johnson\",\n            \"tickerSymbol\": \"JNJ\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u53cb\u83ef\u751f\u6280\u91ab\u85e5\",\n            \"tickerSymbol\": \"4131\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-07-15\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-07-15\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Biogen \u7684\u6297 tau \u85e5\u7269\u548c\u4e4b\u524d\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u904e\u53bb Biogen \u7684 Leqembi \u662f\u6e05\u9664\u5927\u8166\u4e2d\u7684 amyloid \u6591\u584a\uff0c\u800c\u6297 tau \u85e5\u7269\u7684\u76ee\u6a19\u662f\u53e6\u4e00\u7a2e\u75c5\u7406\u86cb\u767d\u2014\u2014tau \u7e8f\u7d50\uff1b\u79d1\u5b78\u754c\u8a8d\u70ba\u5169\u7a2e\u75c5\u7406\u90fd\u662f\u963f\u8332\u6d77\u9ed8\u75c7\u7684\u6838\u5fc3\u7279\u5fb5\uff0c\u4f46 tau \u8def\u7dda\u5c1a\u672a\u6709\u4efb\u4f55\u85e5\u7269\u6210\u529f\u901a\u904e\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a57\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Biogen \u80a1\u50f9\u4e0b\u8dcc\u4ee3\u8868\u9019\u500b\u85e5\u7269\u5b8c\u5168\u5931\u6557\u4e86\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u4e0d\u4e00\u5b9a\u662f\u5b8c\u5168\u5931\u6557\uff0c\u4f46\u6578\u64da\u672a\u9054\u5e02\u5834\u9810\u671f\u662f\u4e3b\u56e0\uff1bBiogen \u7ba1\u7406\u5c64\u6b63\u4e3b\u5f35\u90e8\u5206\u6b21\u65cf\u7fa4\uff08subgroup\uff09\u4ecd\u6709\u7642\u6548\u4fe1\u865f\uff0c\u5f8c\u7e8c\u662f\u5426\u7e7c\u7e8c\u958b\u767c\u53d6\u6c7a\u65bc\u66f4\u5b8c\u6574\u7684\u6578\u64da\u5206\u6790\u8207\u76e3\u7ba1\u6a5f\u69cb\u6e9d\u901a\u7d50\u679c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u6b21\u5931\u6557\u5c0d\u5176\u4ed6\u516c\u53f8\u7684\u963f\u8332\u6d77\u9ed8\u75c7\u85e5\u7269\u7814\u767c\u6709\u4ec0\u9ebc\u5f71\u97ff\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u77ed\u671f\u5167\u5c07\u4f7f tau \u9776\u5411\u85e5\u7269\u7684\u6388\u6b0a\u8207\u878d\u8cc7\u96e3\u5ea6\u63d0\u9ad8\uff0c\u8cc7\u91d1\u53ef\u80fd\u66f4\u96c6\u4e2d\u6d41\u5411\u5df2\u6709\u81e8\u5e8a\u9a57\u8b49\u7684 amyloid \u6e05\u9664\u7642\u6cd5\uff08\u5982 Lilly \u7684 donanemab\uff09\uff1b\u4f46\u9577\u671f\u800c\u8a00\u4e26\u4e0d\u4ee3\u8868 tau \u7b56\u7565\u5df2\u6b7b\uff0c\u7cbe\u6e96\u60a3\u8005\u5206\u5c64\u4ecd\u662f\u53ef\u80fd\u7684\u7834\u5c40\u95dc\u9375\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u4ec0\u9ebc\u662f\u53cd\u5411\u4f75\u8cfc\u4e0a\u5e02\uff1fAvere \u70ba\u4ec0\u9ebc\u4e0d\u9078\u64c7\u50b3\u7d71 IPO\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53cd\u5411\u4f75\u8cfc\u662f\u6307\u79c1\u4eba\u516c\u53f8\u6536\u8cfc\u4e00\u5bb6\u5df2\u4e0a\u5e02\u4f46\u696d\u52d9\u505c\u6eef\u7684\u6bbc\u516c\u53f8\uff08\u6b64\u8655\u70ba NextCure\uff09\uff0c\u85c9\u6b64\u7e5e\u904e\u50b3\u7d71 IPO \u7e41\u8907\u5be9\u67e5\u6d41\u7a0b\u5feb\u901f\u639b\u724c\uff1b\u5728\u7576\u524d\u751f\u6280 IPO \u5e02\u5834\u4f4e\u8ff7\u3001\u5be9\u67e5\u56b4\u683c\u7684\u74b0\u5883\u4e0b\uff0c\u6b64\u65b9\u5f0f\u53ef\u7bc0\u7701\u6642\u9593\u8207\u627f\u92b7\u6210\u672c\uff0c\u4f46\u4ee3\u50f9\u662f\u9700\u627f\u63a5\u6bbc\u516c\u53f8\u7684\u6b77\u53f2\u80a1\u6771\u7d50\u69cb\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"IL-23 \u6291\u5236\u5291\u548c\u76ee\u524d\u5e02\u5834\u4e0a\u7684\u751f\u7269\u88fd\u5291\u6709\u4ec0\u9ebc\u7af6\u722d\u512a\u52e2\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u73fe\u6709 IL-23 \u6291\u5236\u5291\uff08\u5982 Skyrizi\u3001Tremfya\uff09\u5747\u70ba\u6ce8\u5c04\u5291\u578b\uff0c\u82e5 Avere \u5f15\u9032\u7684\u7ff0\u68ee\u85e5\u7269\u80fd\u5be6\u73fe\u53e3\u670d\u7d66\u85e5\uff0c\u5c07\u5927\u5e45\u63d0\u5347\u60a3\u8005\u7528\u85e5\u4fbf\u5229\u6027\uff0c\u6709\u6a5f\u6703\u5728\u4e7e\u766c\u3001\u767c\u708e\u6027\u8178\u75c5\u7b49\u6162\u6027\u9069\u61c9\u75c7\u4e2d\u6436\u5360\u5e02\u4f54\uff1b\u53e3\u670d\u7d66\u85e5\u662f\u6574\u500b\u514d\u75ab\u9818\u57df\u516c\u8a8d\u7684\u4e0b\u4e00\u500b\u5dee\u7570\u5316\u6230\u5834\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u7ff0\u68ee\u88fd\u85e5\u7684\u85e5\u7269\u5728\u4e2d\u570b\u5df2\u7d93\u4e0a\u5e02\u4e86\u55ce\uff1f\u9019\u6b21\u4ea4\u6613\u53ea\u6388\u6b0a\u54ea\u4e9b\u5730\u5340\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u6839\u64da\u4ea4\u6613\u67b6\u69cb\uff0cAvere \u53d6\u5f97\u7684\u662f\u4e2d\u570b\u4ee5\u5916\u7684\u5168\u7403\u5e02\u5834\u6b0a\u5229\uff0c\u7ff0\u68ee\u4fdd\u7559\u4e2d\u570b\u5e02\u5834\uff1b\u8a72\u53e3\u670d IL-23 \u5019\u9078\u85e5\u7269\u76ee\u524d\u7814\u5224\u4ecd\u8655\u81e8\u5e8a\u958b\u767c\u968e\u6bb5\uff0c\u5c1a\u672a\u5728\u4efb\u4f55\u4e3b\u8981\u5e02\u5834\u7372\u6279\u4e0a\u5e02\uff0cAvere \u9700\u81ea\u884c\u63a8\u9032\u897f\u65b9\u5e02\u5834\u7684\u5f8c\u671f\u81e8\u5e8a\u8207\u85e5\u8b49\u7533\u8acb\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-8322","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=8322"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8322\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=8322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}